15q24.1CNV Type: Deletion-Duplication
Largest CNV size: 9500 bp
Statistics Box:
Number of Reports: 13
Number of Reports: 13
Summary Information
Summary statement in development
Additional Locus Information
References
Major Reports
Title
Author, Year
Report Class
CNV Type
Microduplications in an autism multiplex family narrow the region of susceptibility for developmental disorders on 15q24 and implicate 7p21.
Duplication
An evidence-based approach to establish the functional and clinical significance of copy number variants in intellectual and developmental disabili...
Deletion
Copy number variants in extended autism spectrum disorder families reveal candidates potentially involved in autism risk.
Duplication
Phenotypic heterogeneity of genomic disorders and rare copy-number variants.
Deletion-Duplication
Refinement and discovery of new hotspots of copy-number variation associated with autism spectrum disorder.
Deletion
Minor Reports
Title
Author, Year
Report Class
CNV Type
Identifying autism loci and genes by tracing recent shared ancestry.
Deletion
Multiple recurrent de novo CNVs, including duplications of the 7q11.23 Williams syndrome region, are strongly associated with autism.
Deletion-Duplication
Relative burden of large CNVs on a range of neurodevelopmental phenotypes.
Deletion
A discovery resource of rare copy number variations in individuals with autism spectrum disorder.
Deletion
Using extended pedigrees to identify novel autism spectrum disorder (ASD) candidate genes.
Deletion
Performance of case-control rare copy number variation annotation in classification of autism.
Deletion-Duplication
Paternally inherited cis-regulatory structural variants are associated with autism.
Deletion
Cases
Cohort ID
Author, Year
Descripton
Cohort Size
Diagnosis
Age
Gender
CNV Size
Deletion
Duplication
Total CNV's
brandler_18_ASD_replication_cases
Affected individuals from MSSNG cohort (1395 cases from 1187 families) and the Simons Simplex 2 (SSC2) cohort (584 cases from simplex quad families)
1979
Cases diagnosed with ASD
N/A
N/A
2920
1
0
1
chaves_19_ASD/DD/ID_discovery_cases
Patients from the south of Brazil with neurodevelopmental disorders
420
Developmental delay/intellectual disability present in 80% of cases, ASD in 32%
Range, 0-49 years (mean 9.5 9.73 years)
61.90% Male
742953
0
1
1
cukier_11_ASD_discovery_cases
2 autistic individuals from multiplex family 17122 (originally ascertained as part of the Collaborative Autism Project, which was described in Ma et al., 2009 ASD GWAS study)
2
1 diagnosed with autism, 1 diagnosed with ASD (DSM-IV and ADI-R criteria)
Male
5800
0
2
2
engchuan_15_ASD_discovery_cases
Samples from the Autism Genome Project (AGP)
1892
Diagnosis of ASD based on Autism Diagnostic Observation Schedule (ADOS) and Autism Diagnostic Interview-Revised (ADI-R)
N/A
85.78% Male
125767
2
1
3
girirajan_11_ASD_discovery_cases
ASD cases with sporadic autism from the Simons Simplex Collection (SSC)
336
Diagnosis of ASD based on meeting criteria on ADOS, ADI-R, and expert clinical judgment. 246 cases with no intellectual disability, 90 cases with intellectual disability. Exclusion criteria: significant hearing, vision, or motor problems; significant birth complications; a diagnosis of ASD-related disorders, such as Fragile X; or having a relative (up to 3rd degree) with ASD or sibling showing ASD-related symptoms.
92031
1
0
1
girirajan_12_ASD/DD/ID_discovery_cases
Samples from affected children submitted to Signature Genomic Laboratories from 2008-2010.
32587
Developmental delay with or without congenital malformations
1410000
8
4
12
girirajan_13a_ASD_discovery_cases
1979 simplex cases from the Simons Simplex Collection (SSC), 579 multiplex cases from AGRE.
2588
Diagnosis of ASD based on meeting criteria on the Autism Diagnostic Observation Schedule (ADOS) and on the Autism Diagnostic Interview, Revised (ADI-R)
NA
NA
5039
2
0
2
kaminsky_11_DD/ID/ASD_discovery_cases
Cases from the International Standards for Cytogenomic Arrays (ISCA) consortium
15749
Unexplained developmental delay, intellectual disability, dysmorphic features, multiple congenital anomalies, autism spectrum disorders, or clinical features suggestive of a chromosomal syndrome
NA
NA
1379928
1
0
1
morrow_08_ASD_discovery_cases
Affected individuals from 70 families (52 simplex, 18 multiplex) recruited by Homozygosity Mapping Collaborative for Autism (HMCA) used in CNV analysis. This cohort was selected from an original population of affected individuals from 104 families (79 simplex, 25 multiplex; 82.7% male); 88 of these pedigrees have cousin marriages.
94
ASD (based on DSM-IV-TR diagnoses when research scales not available in native language)
9500
1
0
1
prasad_12_ASD_discovery_cases
Unrelated ASD cases recruited from three Canadian sites (Hospital for Sick Children, McMaster University, and Memorial University of Newfoundland); the majority of cases had been previously genotyped with results published in Marshall et al., 2008 and Pinto et al., 2010. 20 cases from initial cohort of 696 were excluded from further analysis (due to CNVs > 5 Mb).
676
Diagnosis of ASD based on meeting criteria on ADI-R and/or ADOS
NA
82.84% Male
8445
1
0
1
salyakina_11_ASD_discovery_cases
ASD patients from extended ASD families (defined as families with at least two affected cousins)
97
ASD. Inclusion criteria: (1) age between 3 and 21 yrs of age; (2) presumptive clinical diagnosis of ASD; (3) diagnosis determined using DSM-IV criteria supported by ADI-R; (4) IQ > 35 or developmental level >18 months as described by VABS
Range, 3-21 yrs.
11028
0
3
3
sanders_11_ASD_discovery_cases
Autistic probands from the Simons Simplex Collection (SSC). 872 probands in quartet families, 272 probands in trios.
1124
ASD diagnosis: 89.5% autism; 8.5% PDD-NOS, 2% Asperger syndrome. Mean full-scale IQ 85.1 1.5 (mean verbal IQ, 81.9 1.7; mean non-verbal IQ, 88.4 1.4)
Mean, 9.1 yrs.
86.1% Male
3387
1
1
2
woodbury-smith_14_ASD_discovery_cases
Probands from 19 extended ASD pedigrees (defined as at least three ASD cases spread across at least two nuclear families); 6 families recruited in Canada, 13 families recruited in the United States
19
Diagnosis of ASD made using combination of ADI-R, ADOS, and clinical judgment in conjunction with DSM-IV criteria.
N/A
N/A
2218
1
0
1
Controls
Cohort ID
Author, Year
Descripton
Cohort Size
Diagnosis
Age
Gender
CNV Size
Deletion
Duplication
Total CNV's
engchuan_15_ASD_discovery_controls
Platform-matched controls from three large studies: SAGE (Study of Addiction Genetics and Environment), Ontario Colorectal Cancer study, and HABC (Health Aging and Body Composition)
2342
Controls; subjects had no previous psychiatric history
N/A
46.67% Male
145707
0
1
1
girirajan_11_ASD_discovery_controls
Control individuals ascertained by NIMH Genetics Initiative. DNA samples from these individuals were obtained from the Rutgers Univ. Cell & DNA Repository.
337
Control. Individuals screened specifically for eight mental health disorders.
85267
2
0
2
girirajan_12_ASD/DD/ID_discovery_controls
Persons found to have no overt neurological disorders during screening for other studies
8329
Control
1410000
0
0
0
girirajan_13a_ASD_discovery_controls1
NIMH control cohort consisting of 207 DNA samples obtained from Rutgers Univ. Cell and DNA Repository, and 373 individuals from ClinSeq study of artherosclerotic disease
580
Control. Individuals from NIMH control cohort negative for DSM-IV criteria for major depression and history of bipolar disorder or psychosis.
NA
NA
0
0
0
0
girirajan_13a_ASD_discovery_controls2
Controls characterized through the Wellcome Trust Case-Control Consortium (WTCCC) for smaller hotspot regions and candidate-gene events
2090
Control
NA
NA
N/A
N/A
N/A
N/A
kaminsky_11_DD/ID/ASD_discovery_controls
Controls from the International Standards for Cytogenomic Arrays (ISCA) consortium
10118
Controls
NA
NA
NA
NA
NA
NA
prasad_12_ASD_discovery_controls
PDx controls [1000 DNA samples from reportedly healthy donors (50.2% male) from BioServe (Beltsville, MD)] and 4139 in-house controls previously reported in Krawcak et al. 2006, Stewart et al. 2009, and Bierut et al. 2010. CNVs identified in controls were used to define rare ASD-specific CNVs.
5139
Control
NA
NA (PDx controls 50.2% male)
8445
0
0
0
salyakina_11_ASD_discovery_controls
Pediatric control samples recruited by Hussman Institute for Human Genomics (HHIG, Univ. of Miami) and Centennial Medical Center (Nashville, TN) as part of preterm birth study (Nashville Borth Cohort, NBC)
838
Controls. Exclusion criteria: participants, or those with first degree relatives, with developmental, behavioral, or neurological conditions
11028
0
0
0
sanders_11_ASD_discovery_controls
Matched siblings of autistic probands from the Simons Simplex Collection (SSC).
872
Controls
Mean, 10.0 yrs.
3301
2
0
2
woodbury-smith_14_ASD_discovery_controls
Platform-matched controls from the KORA and COGEND datasets
2988
Control
N/A
N/A
0
0
0
0
Cases
Cohort ID
Geographical Ancestry
Discovery Method
Platform
Algorithm
Software
Validation Method
brandler_18_ASD_replication_cases
N/A
WGS
Illumina HiSeq X10
ForestSV, Lumpy, Manta, Mobster, SV2
None
chaves_19_ASD/DD/ID_discovery_cases
Brazil
Array SNP
Affymetrix CytoScan 750K, Affymetrix CytoScan HD
Affymetrix ChAS
None
cukier_11_ASD_discovery_cases
European
Solid phase hybridization
Illumina Human 1M Beadchip
PennCNV
qPCR
engchuan_15_ASD_discovery_cases
Caucasian
Solid phase hybridization
Illumina 1M
None
girirajan_11_ASD_discovery_cases
aCGH
Custom microarray targeting 107 genomic hotspot regions (Roche NimbleGen Hotspot v1.0 array; 12 x 135K)
HMM
None
girirajan_12_ASD/DD/ID_discovery_cases
aCGH
BACs aCGH, SignatureChipOS
FISH, aCGH, or confirmation by inheritance
girirajan_13a_ASD_discovery_cases
NA
aCGH
Custom microarray with a high density of probes targeted to 1,367 regions with a susceptible genomic architecture
ADM-2
Agilent Genomic Workbench
aCGH (NimbleGen 135K array)
kaminsky_11_DD/ID/ASD_discovery_cases
NA
aCGH
Agilent 44K, Agilent 105K
Feature Extraction, DNA Analytics
FISH, qPCR, MLPA, aCGH, standard G-banded chromosome analysis
morrow_08_ASD_discovery_cases
Arabic Middle East, Turkey, and Pakistan
Array SNP
Affymetrix 500K
BRLMM
dChip
prasad_12_ASD_discovery_cases
Canada
aCGH
Agilent 1M
ADM-2, DNAcopy (R Bioconductor)
DNA Analytics v4.0.85 (Agilent), DNAcopy
None
salyakina_11_ASD_discovery_cases
Solid phase hybridization
Illumina Human 1Mv1_C BeadChip or Illumina 1M-DuoV3 BeadChip
PennCNV
BeadStudio v3
qPCR
sanders_11_ASD_discovery_cases
White non-Hispanic, 74.5%; mixed, 9.3%, Asian, 4.3%, White Hispanic, 4.0%, African-American, 3.8%; other, 4.2&
Solid phase hybridization
Illumina 1M v1, Illumina 1M v3
PennCNV, QuantiSNP, GNOSIS
woodbury-smith_14_ASD_discovery_cases
US and Canada
Solid phase hybridization
Illumina HumanOmni2.5 BeadChip
PennCNV, QuantiSNP, iPattern
None
Controls
Cohort ID
Geographical Ancestry
Discovery Method
Platform
Algorithm
Software
Validation Method
engchuan_15_ASD_discovery_controls
Caucasian
Solid phase hybridization
Illumina 1M
None
girirajan_11_ASD_discovery_controls
aCGH
Custom microarray targeting 107 genomic hotspot regions (Roche NimbleGen Hotspot v1.0 array; 12 x 135K)
HMM
None
girirajan_12_ASD/DD/ID_discovery_controls
aCGH
BACs ACGH (SignatureChipoWG) or oligoarray (SignatureChipOS)
girirajan_13a_ASD_discovery_controls1
NA
aCGH
Custom microarray with a high density of probes targeted to 1,367 regions with a susceptible genomic architecture
ADM-2
Agilent Genomic Workbench
None
girirajan_13a_ASD_discovery_controls2
NA
Solid phase hybridization
Illumina 1.2M SNP microarray
None
kaminsky_11_DD/ID/ASD_discovery_controls
NA
aCGH
Agilent 44K, Agilent 105K
Feature Extraction, DNA Analytics
prasad_12_ASD_discovery_controls
NA
aCGH
Agilent 1M
ADM-2, DNAcopy (R Bioconductor)
DNA Analytics v4.0.85 (Agilent), DNAcopy
salyakina_11_ASD_discovery_controls
727 Caucasian, 111 African-American
sanders_11_ASD_discovery_controls
Solid phase hybridization
Illumina 1M v1 or Illumina 1M v3
PennCNV, QuantiSNP, GNOSIS
woodbury-smith_14_ASD_discovery_controls
Predominantly European
Solid phase hybridization
Illumina HumanOmni2.5 BeadChip
PennCNV, QuantiSNP, iPattern
None
Cases
Patient ID
Author, Year
Age
Gender
Primary Diagnosis
Clinical Profile
Cognitive Profile
CNV Start
CNV End
CNV Size
Genome Build
Type Method
Validation
brandler_18_ASD_replication_cases-caseAU4462302
N/A
M
ASD
Case from MSSNG cohort
73056240
73059159
2920
GRCh38
Deletion
No
chaves_19_ASD/DD/ID_discovery_cases-case223
10 yrs.
M
Developmental delay and intellectual disability
Short stature, intrauterine growth retardation, developmental delay, mild intellectual disability, facial dysmorphism (narrow face, dolichocephaly, high-arched palate, microtia), nipple hypertelorism, constipation
Mild intellectual disability
72546464
73289416
742953
GRCh38
Duplication
No
cukier_11_ASD_discovery_cases-case0100
NA
M
Autism
Walking at 18 months, first word at 40 months, phrase speech at 57 months. EEG findings of uncertain significance, but no clinical seizures. History of allergies, senosry problems, and hyperactivity. No dysmorphic features, head circumference in high normal range. First cousin of discovery case 0101.
Full scale IQ=46, Vineland adaptive behavior composite=55
74456674
74468482
11809
GRCh38
Duplication
Yes
cukier_11_ASD_discovery_cases-case0101
NA
M
ASD
Initially diagnosed with ADHD, depressive disorder, and a reading disability. Significant social problems & no inclination to interact with peers. Walking at 11 months, first words at 12 months, phrase speech at 24 months. Articulation and oral motor problems, awkward gait, overly acute hearing. First cousin of discovery case 0100.
Full scale IQ=99, Vineland adaptive behavior composite=65
74456674
74468482
11809
GRCh38
Duplication
Yes
engchuan_15_ASD_discovery_cases-case3016_3
N/A
N/A
ASD
Diagnosis of ASD based on Autism Diagnostic Observation Schedule (ADOS) and Autism Diagnostic Interview-Revised (ADI-R)
74120207
74202605
82399
GRCh38
Duplication
No
engchuan_15_ASD_discovery_cases-case4524_1
N/A
N/A
ASD
Diagnosis of ASD based on Autism Diagnostic Observation Schedule (ADOS) and Autism Diagnostic Interview-Revised (ADI-R)
73065610
73191377
125768
GRCh38
Deletion
No
engchuan_15_ASD_discovery_cases-case6249_4
N/A
N/A
ASD
Diagnosis of ASD based on Autism Diagnostic Observation Schedule (ADOS) and Autism Diagnostic Interview-Revised (ADI-R)
73501146
73531700
30555
GRCh38
Deletion
No
girirajan_11_ASD_discovery_cases-Si262
9
M
Autism
ADOS score: NA. Vineland composite score: NA.
Mental retardation/intellectual disability: unknown. Full-scale IQ, NA; Verbal IQ, NA; Non-verbal IQ, NA.
74750344
74842375
92032
GRCh38
Deletion
No
girirajan_13a_ASD_discovery_cases-12132.p1
N/A
N/A
ASD
Diagnosis of ASD based on meeting criteria on the Autism Diagnostic Observation Schedule (ADOS) and on the Autism Diagnostic Interview, Revised (ADI-R)
N/A
72709127
72714166
5040
GRCh38
Deletion
Yes
girirajan_13a_ASD_discovery_cases-AU084503
N/A
N/A
ASD
Diagnosis of ASD based on meeting criteria on the Autism Diagnostic Observation Schedule (ADOS) and on the Autism Diagnostic Interview, Revised (ADI-R)
N/A
72709127
72714166
5040
GRCh38
Deletion
Yes
kaminsky_11_DD/ID/ASD_discovery_cases-ISCA00004641
NA
NA
Developmental delay/intellectual disability/ASD
Clinical profile NA
Cognitive profile NA
72671629
74051557
1379929
GRCh38
Deletion
Yes
morrow_08_ASD_discovery_cases-case3901
NA
ASD
NA
NA
72361000
72371000
9500
Unknown
Deletion
No
prasad_12_ASD_discovery_cases-case89675
NA
M
ASD
Diagnosis of ASD based on meeting criteria on ADI-R and/or ADOS. Novel CNV
71804599
71813043
8445
Unknown
Deletion
No
salyakina_11_ASD_discovery_cases-17122_001
M
Autism
Abnormal EEGs. ADHD symptoms. Language delays, fine motor delay, low muscle tone/muscle weakness. Macrocephaly.
Moderate intellectual disability, learning disabilities.
74458793
74469821
11029
GRCh38
Duplication
Yes
salyakina_11_ASD_discovery_cases-17122_100
M
Autism
ADHD symptoms. Sensory deficits. Language delays, regression at 11 months.
74458793
74469821
11029
GRCh38
Duplication
Yes
salyakina_11_ASD_discovery_cases-17122_101
M
Autism
ADHD symptoms. Mood disorder not otherwise specified (NOS). Reading disorder. Mild oral motor and articulation delays. Awkward gait.
Learning disabilities.
74458793
74469821
11029
GRCh38
Duplication
Yes
sanders_11_ASD_discovery_cases-11134.p1
13.6
M
Autism
NA
Full-scale IQ, 117; non-verbal IQ, 115; verbal IQ 116
72671364
72674751
3388
GRCh38
Duplication
No
sanders_11_ASD_discovery_cases-12032.p1
10.3
M
Autism
NA
Full-scale IQ, 75; non-verbal IQ, 71; verbal IQ, 84
74428830
74429720
891
GRCh38
Deletion
No
woodbury-smith_14_ASD_discovery_cases-case14
N/A
M
ASD
Family history: broad autism phenotype (BAP)-defined father.
74014292
74016509
2218
GRCh38
Deletion
No
Controls
Patient ID
Author, Year
Age
Gender
Primary Diagnosis
Clinical Profile
Cognitive Profile
CNV Start
CNV End
CNV Size
Genome Build
Type Method
Validation
engchuan_15_ASD_discovery_controls-controlHABC_901138_901138
N/A
N/A
Control
No previous psychiatric history
73797452
73943159
145708
GRCh38
Duplication
No
girirajan_11_ASD_discovery_controls-NIMH_107
NA
NA
Control
NA
NA
74791837
74842375
50539
GRCh38
Deletion
No
girirajan_11_ASD_discovery_controls-NIMH_231
NA
NA
Control
NA
NA
74761557
74846824
85268
GRCh38
Deletion
No
sanders_11_ASD_discovery_controls-12091.s1
7.2
M
Control (matched sibling)
NA
NA
73727495
73730796
3302
GRCh38
Deletion
No
sanders_11_ASD_discovery_controls-12964.s1
8.5
M
Control (matched sibling)
NA
NA
74746114
74749010
2897
GRCh38
Deletion
No
Cases
Patient ID
Validation Description
Primary Disorder Inheritence
Inheritence
Family Profile
Disease Segregation
Gene Content
Altered Gene Expression
brandler_18_ASD_replication_cases-caseAU4462302
No validation step reported
Paternal
NEO1
chaves_19_ASD/DD/ID_discovery_cases-case223
Unknown
MIR630,RN7SL853P,NPM1P42,FKBP1AP2,NPM1P43,GOLGA6B,HIGD2B,BBS4,ADPGK,ADPGK-AS1,ARIH1,LINC02259,NEO1
cukier_11_ASD_discovery_cases-case0100
qPCR
Maternal
Multiplex
Unknown
UBL7-AS1,UBL7
cukier_11_ASD_discovery_cases-case0101
qPCR
Maternal
Simplex
NA
UBL7-AS1,UBL7
engchuan_15_ASD_discovery_cases-case3016_3
Unknown
ISLR,ISLR2,STRA6
engchuan_15_ASD_discovery_cases-case4524_1
Unknown
FKBP1AP2,NPM1P43,NEO1
engchuan_15_ASD_discovery_cases-case6249_4
Unknown
REC114
girirajan_11_ASD_discovery_cases-Si262
Unknown
Simplex
CYP1A2,MIR4513,CPLX3,MIR6882,CSK,LMAN1L,ULK3
girirajan_13a_ASD_discovery_cases-12132.p1
aCGH (NimbleGen 135K array)
Maternal
Simplex
Unknown
BBS4
girirajan_13a_ASD_discovery_cases-AU084503
aCGH (NimbleGen 135K array)
Paternal
Multiplex
Unknown
BBS4
kaminsky_11_DD/ID/ASD_discovery_cases-ISCA00004641
FISH, qPCR, MLPA, aCGH, or standard G-banded chromosome analysis
Unknown
Unknown
Unknown
NPM1P42,FKBP1AP2,NPM1P43,MRPS15P1,NPTN-IT1,HIGD2B,BBS4,ADPGK,ADPGK-AS1,HCN4,NPTN,CD276,INSYN1,INSYN1-AS1,TBC1D21,LOXL1,STOML1,PML,NEO1,REC114,LOXL1-AS1
morrow_08_ASD_discovery_cases-case3901
Paternal
NA
NA
CCDC33
prasad_12_ASD_discovery_cases-case89675
Unknown
Unknown
Unknown
0 genes
salyakina_11_ASD_discovery_cases-17122_001
qPCR
Maternal
Multiplex
Segregated
UBL7-AS1,UBL7
salyakina_11_ASD_discovery_cases-17122_100
qPCR
Maternal
Multiplex
Segregated
UBL7-AS1,UBL7
salyakina_11_ASD_discovery_cases-17122_101
qPCR
Maternal
Simplex
Segregated
UBL7-AS1,UBL7
sanders_11_ASD_discovery_cases-11134.p1
Paternal
Simplex (trio)
NA
sanders_11_ASD_discovery_cases-12032.p1
Both parents
Simplex (quad-proband matched)
Segregated
SEMA7A
woodbury-smith_14_ASD_discovery_cases-case14
Paternal
Possible multi-generational (CNV transmitted from BAP-defined parent to ASD diagnosed offspring)
Unknown
PML
Controls
Patient ID
Validation Description
Primary Disorder Inheritence
Inheritence
Family Profile
Disease Segregation
Gene Content
Altered Gene Expression
engchuan_15_ASD_discovery_controls-controlHABC_901138_901138
Unknown
TBC1D21,LOXL1,LOXL1-AS1
girirajan_11_ASD_discovery_controls-NIMH_107
Unknown
CPLX3,MIR6882,CSK,LMAN1L,ULK3
girirajan_11_ASD_discovery_controls-NIMH_231
Unknown
MIR4513,CPLX3,MIR6882,CSK,LMAN1L,SCAMP2,ULK3
sanders_11_ASD_discovery_controls-12091.s1
Paternal
Simplex (quad)
NA
sanders_11_ASD_discovery_controls-12964.s1
Unknown
Simplex (quad)
NA
CYP1A2
No Animal Model Data Available


